NCT04406545View on ClinicalTrials.gov

Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions
Coronavirus InfectionEndothelial DysfunctionMicrovascular Rarefaction
Interventions
OTHER

evaluation of skin microvascular flow and reactivity

evaluation of skin microvascular flow and reactivity using laser Doppler perfusion monitoring

Trial Locations (1)

21040-360

National Institute of Cardiology, Rio de Janeiro

All Listed Sponsors
lead

National Institute of Cardiology, Laranjeiras, Brazil

OTHER_GOV

NCT04406545 - Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. | Biotech Hunter | Biotech Hunter